PPD (PPD) Stock Price
PPD Price
Revenue has compounded at 15.0% per year over the past 4 years to 4.68 B USD. Earnings per share have declined at 23.9% per year over the last 3 years. PPD's net margin stands at 3.3%, down from 6.8% several years earlier.
PPD stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of PPD over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how PPD stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing PPD's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | PPD Price |
|---|
PPD Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
PPD Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021e | 2022e | 2023e | 2024e | 2025e |
|---|---|---|---|---|---|---|---|---|---|
| 2.68 | 3.00 | 3.75 | 4.03 | 4.68 | 6.01 | 6.41 | 7.02 | 7.47 | 8.03 |
| – | 12.02 | 24.89 | 7.55 | 16.13 | 28.35 | 6.69 | 9.52 | 6.45 | 7.51 |
| 48.23 | 48.78 | 39.33 | 40.24 | 38.41 | 38.41 | 38.41 | 38.41 | 38.41 | 38.41 |
| 1.29 | 1.46 | 1.47 | 1.62 | 1.80 | 2.31 | 2.46 | 2.70 | 2.87 | 3.09 |
| 314.00 | 261.00 | 402.00 | 371.00 | 509.00 | – | – | – | – | – |
| 11.72 | 8.70 | 10.73 | 9.20 | 10.87 | – | – | – | – | – |
| 183.00 | 296.00 | 104.00 | 47.00 | 153.00 | 567.00 | 647.00 | 736.00 | 830.00 | 946.00 |
| – | 61.75 | -64.86 | -54.81 | 225.53 | 270.59 | 14.11 | 13.76 | 12.77 | 13.98 |
| 347.00 | 294.00 | 279.00 | 281.00 | 347.00 | 347.00 | 347.00 | 347.00 | 347.00 | 347.00 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales PPD generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue PPD retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare PPD's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares PPD has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against PPD's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
PPD stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
PPD Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
PPD business model & stock analysis
PPD SWOT Analysis
Strengths
PPD Inc. possesses several key strengths that contribute to its success and competitive advantage:
- Strong reputation and brand recognition in the industry.
- Diverse portfolio of products and services, catering to various market segments.
- Well-established distribution network, ensuring wide market coverage.
- Highly skilled and experienced workforce, fostering innovation and efficiency.
Weaknesses
Despite its strengths, PPD Inc. also faces certain weaknesses that pose challenges:
- Reliance on a limited number of key customers, increasing vulnerability to changes in their preferences or market conditions.
- Higher operational costs compared to some competitors.
- Limited geographic reach, potentially missing out on untapped markets.
- Integration and communication challenges across different departments and divisions within the organization.
Opportunities
PPD Inc. has identified several opportunities that it can capitalize on:
- Expanding into emerging markets with high growth potential.
- Developing new and innovative products to meet evolving customer needs.
- Acquiring smaller competitors to strengthen market position and increase market share.
- Forming strategic partnerships or collaborations to access new technologies or markets.
Threats
PPD Inc. also faces certain threats that may impact its growth and profitability:
- Intense competition from existing and new players in the market.
- Changing regulatory landscapes and compliance requirements.
- Economic downturns or fluctuations, affecting customer spending and demand.
- Rapid technological advancements, necessitating continuous adaptation and investment.
PPD Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
PPD Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
PPD historical P/E ratio, EBIT multiple, and P/S ratio
PPD annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
PPD shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
PPD Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 4/28/2021 | Downgrade | OverweightNeutral | 59 | |
| 4/20/2021 | Downgrade | BuyHold | 56 | |
| 4/19/2021 | Downgrade | OutperformNeutral | 72 | |
| 4/19/2021 | Downgrade | BuyNeutral | 48 | |
| 4/16/2021 | Downgrade | OutperformPerform | – | |
| 4/16/2021 | Downgrade | BuyHold | – | |
| 4/16/2021 | Downgrade | OverweightEqual Weight | 43 | |
| 4/16/2021 | Downgrade | BuyHold | 54 | |
| 4/15/2021 | Downgrade | OutperformNeutral | 62 | |
| 3/3/2021 | Maintained | Overweight | 57 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
PPD Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 3/1/2022 | 0.45USD | - | 1.49 BUSD | - | 2021 Q4 |
| 10/27/2021 | 0.38USD | - | 1.43 BUSD | - | 2021 Q3 |
| 7/28/2021 | 0.34USD | - | 1.34 BUSD | - | 2021 Q2 |
| 4/27/2021 | 0.32USD | - | 1.31 BUSD | - | 2021 Q1 |
| 2/23/2021 | 0.36USD | - | 1.30 BUSD | - | 2020 Q4 |
| 10/27/2020 | 0.32USD | - | 1.15 BUSD | - | 2020 Q3 |
| 8/4/2020 | 0.22USD | - | 939.49 MUSD | - | 2020 Q2 |
| 5/6/2020 | 0.22USD | - | 1.05 BUSD | - | 2020 Q1 |
| 3/4/2020 | 0.27USD | - | 1.06 BUSD | - | 2019 Q4 |
PPD shareholder structure
| % | Name |
|---|---|
22.02569% | |
15.91487% | |
15.91487% | |
3.42223% | |
3.03887% | |
1.66822% |
PPD Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
22.10% | SEC ↗ | |
22.10% | SEC ↗ | |
15.90% | SEC ↗ | |
15.90% | SEC ↗ | |
15.10% | SEC ↗ | |
15.10% | SEC ↗ | |
15.10% | SEC ↗ | |
15.10% | SEC ↗ | |
15.10% | SEC ↗ | |
15.10% | SEC ↗ |
Frequently asked questions about PPD
PPD Inc is a leading global contract research organization (CRO) providing comprehensive, integrated drug development and laboratory services. Their business model revolves around offering end-to-end solutions to pharmaceutical and biotech companies, guiding them through the entire drug development process. PPD Inc offers a wide range of services including clinical research, data management, biostatistics, and regulatory affairs. With a focus on quality, efficiency, and innovation, PPD Inc helps clients accelerate the development of life-changing therapies. Through their extensive expertise, efficient processes, and strategic partnerships, PPD Inc plays a crucial role in advancing healthcare outcomes and bringing new treatments to patients worldwide.
PPD Inc is primarily active in the pharmaceutical and biotechnology industries.
The main competitors of PPD Inc in the market include QuintilesIMS, LabCorp, Icon, and Covance.
PPD Inc is a leading global contract research organization (CRO) specializing in drug development, laboratory services, and clinical trial management. Founded in 1985, PPD has a rich history and a strong background in providing innovative solutions to the pharmaceutical, biotechnology, and medical device industries. The company offers a comprehensive range of services, including early development, clinical research, laboratory services, and post-approval studies. PPD Inc has established itself as a trusted partner for the life sciences industry, delivering high-quality results, efficiency, and expertise in advancing healthcare solutions. With a global presence and a team of experienced professionals, PPD continues to be at the forefront of advancing clinical research and improving patient outcomes.
PPD Inc has achieved significant milestones throughout its history. Some noteworthy achievements include successfully conducting over 230,000 clinical trials, establishing a global presence in more than 46 countries, and consistently delivering innovative solutions to the life sciences industry. The company has also been recognized for its exceptional expertise in clinical research, data management, and regulatory affairs. PPD Inc's commitment to quality and customer satisfaction has enabled it to be a reliable partner for pharmaceutical, biotechnology, and medical device companies worldwide. With its strong track record and industry leadership, PPD Inc continues to make significant strides in advancing healthcare and improving patient outcomes.
PPD Inc primarily operates in over 50 countries and regions worldwide. With a strong global presence, the company offers its comprehensive range of clinical research and laboratory services to clients across various industries. PPD Inc's key markets include the United States, Europe, Asia Pacific, and Latin America. The company's extensive network and expertise allow it to effectively serve clients on a global scale, helping them navigate the complexities of drug development and deliver innovative solutions. PPD Inc's commitment to expanding its presence in emerging markets reinforces its position as a leading provider of life sciences services worldwide.
PPD Inc represents a strong set of values and a clear corporate philosophy. The company focuses on delivering exceptional customer service, fostering a culture of innovation, and maintaining the highest standards of integrity. PPD Inc aims to provide reliable and efficient solutions in the fields of healthcare and clinical research. With its commitment to excellence, PPD Inc strives to deliver value to its clients and contribute to better patient outcomes. The company's dedication to these principles has established it as a trusted leader in the industry, making PPD Inc a go-to choice for businesses and individuals seeking reliable healthcare and clinical research services.
Converted at the current exchange rate, the PPD share trades at 40.69 EUR (47.28 USD).
The PPD share (PPD) is listed on 1 stock exchanges, including: NASDAQ (PPD).
PPD Inc is an international pharmaceutical company headquartered in the USA with branches in Europe, Asia, Africa, and Australia. The company operates in the areas of clinical research, pharmacovigilance, laboratory services, and consulting, offering comprehensive solutions to its clients for the development, approval, and monitoring of drugs and medical devices. One of PPD's main divisions is clinical research. The company works closely with pharmaceutical and biotechnology companies, as well as academic research institutions, to conduct clinical trials. PPD provides all the necessary services for conducting a clinical trial, from study design to subject recruitment, data analysis, and reporting. PPD has extensive experience in all phases of clinical research, from Phase I to Phase IV, and has successfully brought numerous drugs to market in the past. Another important division of PPD is pharmacovigilance. Here, the company collects and analyzes data on adverse drug reactions and provides recommendations for risk minimization. PPD works closely with regulatory authorities worldwide to ensure that all data on adverse drug reactions are accurately recorded and analyzed. In addition, PPD offers laboratory services. The company's portfolio includes a wide range of laboratory tests, including bioanalytical tests and safety tests. PPD has extensive expertise in analyzing biological samples, including blood, urine, saliva, and stool samples. The company specializes in identifying molecular markers that are important for disease diagnosis or monitoring therapy success. PPD also offers comprehensive consulting services. Here, the company supports its clients in the development of new therapies and drugs and provides recommendations for optimizing study design and methods. PPD has extensive experience in working with the FDA and other regulatory authorities worldwide, developing strategies for risk minimization and compliance with regulatory requirements. PPD offers a wide range of products and services specifically tailored to the needs of pharmaceutical and biotechnology companies. The company is committed to offering innovative solutions to its clients to accelerate the development of new drugs and therapies. To this end, PPD has made significant investments in its research and development activities in recent years and works closely with customers and partners to develop new and innovative treatment options. Overall, PPD's business model is oriented towards the needs of the pharmaceutical and biotechnology industry. The company offers comprehensive solutions to its clients for the development, approval, and monitoring of drugs and medical devices. PPD is a key partner for innovation in drug development and has successfully brought numerous therapies and drugs to market in the past.
The revenue cannot currently be calculated for PPD.
The profit cannot currently be calculated for PPD.
The P/E ratio cannot be calculated for PPD at the moment.
The P/S cannot be calculated for PPD currently.
The Eulerpool Quality Score for PPD is 3/10.
The ISIN of PPD is US69355F1021. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of PPD is A2PX5V. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of PPD is PPD. The ticker symbol is used to trade PPD shares on the stock exchange.
PPD paid dividends every year for the past 0 years.
PPD is assigned to the 'Health' sector.
The dividends of PPD are distributed in USD.
PPD stock
PPD Peer Group
PPD Ticker
All fundamentals and in-depth analysis of PPD
Our stock analysis for PPD stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PPD. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.